Clinical Research Directory

Critical Care Outcomes of Hematologic Oncology Patients

Sponsor: Mount Sinai Hospital, Canada

Summary

Hematologic malignancy patients are admitted to ICU in increasing numbers. Successful ICU intervention has led to an increasing number of ICU survivors; however, there is a lack of information available about these patients' long term survival and quality of life. There is little Canadian data regarding ICU survival and regarding 1-year survival and functional outcomes in this group of patients. Over 500 patients are admitted annually to Canadian ICUs with an underlying hematologic malignancy or stem cell transplant, yet there is a paucity of up to date long-term outcome data. This information will facilitate a better understanding who would best benefit from critical care interventions and the impact of critical illness on their level of function at 1 year as well as survival.

Official title: Critical Care Outcomes of Patients With Hematologic Malignancy and Hematopoietic Cell Transplantation

Key Details

Conditions

Locations (13)